HOUSTON, June 23, 2016 /PRNewswire/ — MedSource announced today that it has selected Datatrial’s nowEDC™ platform as its e-clinical software solution of choice.  This latest decision demonstrates MedSource’s commitment to provide the best possible value to their clients by offering a state-of-the-art electronic data capture (EDC) solution, nowEDC.  The preferred relationship establishes nowEDC as the EDC platform of choice in exchange for preferred pricing for MedSource’s full-service clients.  “nowEDC has long been a preferred EDC platform by our clients and our staff,” said MedSource president and CEO, Eric Lund. “The real-time dynamic reporting capabilities are a significant advantage for our biotech clients and any client who wants immediate access to their data, and who desires the ability to customize reports whenever they choose.  It is a platform that provides more accuracy and flexibility than anything we have worked with in the industry.  We are excited to offer nowEDC as a solution to our clients and expand our relationship with Datatrial.”

Key Advantages of nowEDC software:

  • Dynamic eCRF Deployment. With the needs of complex study such as orphan or rare indications or a dose escalation study in oncology patients for example, amendments are not only common, they are expected. With dynamic electronic case report form (eCRF) deployment, eCRFs are deployed as patients progress on study making amendments easier to roll out.
  • Real-Time Data Access. nowEDC provides real-time access to the data while other systems cache data for reporting. Instead of waiting for data to refresh, you can visualize data and run reports in real-time.
  • Dynamic Reporting. Nothing is more important to the trial than the quality of its data, but a close second is access to that data. nowEDC offers a dynamic reporting tool that has real-time access to its data. Not only are standard and customized reports provided up front, but sponsors and clinical team users can build their own reports at any time allowing for quick decision making for clients.
  • Agency Approved. nowEDC is a fully validated and compliant system meeting FDA 21 CFR Part 11 and EU Annex 11 standards. Clients should expect nothing less than industry standards and agency compliance.

“We are excited that MedSource has chosen nowEDC as their EDC software of choice,” said Datatrial CEO Emma Banks. “We have been a partner with MedSource for over a decade now and this decision further strengthens our relationship for future growth.  We look forward to continuing to serve MedSource and their clients with our best in class nowEDC software and e-clinical and data solutions.”

About MedSource
MedSource is recognized as an award winning, full-service clinical research organization (CRO) focusing on complex study designs and complex diseases with a particular expertise in oncology and central nervous system disorders. MedSource began as a specialized clinical monitoring group and has consistently expanded to add services and staff to increase the value we can deliver to our clients. With offices throughout North America, our focus on quality, consistency and transparency has been foundational to our growth.

About nowEDC
The nowEDC system provides data capture, verification and validation, query management, data extract, IWRS and real-time reporting in one integrated system. nowEDC is easy-to-use, fully validated and is highly configurable. The flexible aspects of nowEDC also make it a natural fit for handling both complex trial designs as well as adaptive clinical trials.

About Datatrial
Datatrial is a clinical biometrics and technology organization specializing in complete study delivery. We offer a full range of services including Data Management, Statistics and Medical Writing. With headquarters in Newcastle upon Tyne, UK and offices in Boston MA and BioHub at Alderley Park, UK we are very able to support global clinical development programs. Since 1999, we have been serving the pharmaceutical community through our commitment to service and quality in every aspect of the work that we do. With involvement in over 300 clinical trials, across 25 therapeutic areas and with extensive oncology experience we will work with you to develop a study plan that best fits your needs.

Contact:
Matthew Wagener
mwagener@medsource.com
281-286-2003

Link to press release: http://www.prnewswire.com/news-releases/medsource-announces-nowedc-as-electronic-data-capture-platform-of-choice-300289396.html?utm_content=32324063&utm_medium=social&utm_source=twitter